What is Tomo Drug Testing?
Established in 1991, Tomo Drug Testing operates as a comprehensive provider of drug and alcohol screening services, specializing in Department of Transportation (DOT) compliance and Drug-Free Workplace programs. The company serves a diverse clientele across both public and private sectors, offering a robust suite of solutions that includes onsite testing, program administration, and judicial services. By maintaining a widespread network of locations throughout the United States, Tomo ensures that organizations can effectively manage risk, maintain regulatory adherence, and foster safer environments for employees and the public alike. Their operational model is built on the dual pillars of convenience and accuracy, which are essential for high-stakes compliance environments.
How much funding has Tomo Drug Testing raised?
Tomo Drug Testing has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Tomo Drug Testing
PPP
Public-Private Partnership
What's next for Tomo Drug Testing?
With this late-stage funding, Tomo Drug Testing is well-positioned to accelerate its strategic growth initiatives and enhance its technological infrastructure. The company is expected to leverage this capital to optimize its program administration platforms and potentially expand its service delivery capabilities to meet the evolving demands of workplace safety regulations. By focusing on operational efficiency and market penetration, Tomo aims to reinforce its status as a premier partner for entities requiring rigorous, reliable, and scalable screening solutions. The infusion of resources will likely support the integration of advanced diagnostic tools and the expansion of its national service network, ensuring the firm remains at the forefront of the occupational health industry.
See full Tomo Drug Testing company page
